Autonomix Medical Announces 1-for-21 Reverse Stock Split to Maintain Nasdaq Listing

Key Facts

Amid mounting regulatory pressure on micro-cap companies to maintain their standing on major exchanges, Autonomix Medical has taken a decisive step to restructure its equity. The company announced a 1-for-21 reverse stock split of its common stock following an amendment to its certificate of incorporation. This action is specifically designed to meet the minimum bid price requirements necessary for continued listing on the Nasdaq Stock Market.

This corporate action comes as small-cap medical technology firms face heightened volatility, with reverse splits often viewed as a defensive maneuver to prevent delisting. Per market data, AMIX shares closed at $0.389 on June 17, 2026, significantly below the standard $1.00 minimum threshold required by Nasdaq. Compared to industry peers that have undergone similar restructuring, this move reduces the total shares outstanding while proportionally increasing the nominal share price.

Investors should closely monitor market reaction to this structural change, as the stock stood at $0.389 (close June 17, 2026) with a daily range between $0.374 and $0.3958. Looking ahead at the economic calendar, broader market sentiment may be influenced by the Michigan Consumer Sentiment index, which recently printed at 48.9, potentially impacting risk appetite for healthcare and growth stocks in upcoming sessions.